Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 2
2004 2
2005 7
2006 4
2007 2
2008 3
2009 1
2010 5
2011 4
2012 6
2013 3
2014 6
2015 4
2016 7
2017 2
2018 2
2019 11
2020 6
2021 6
2022 5
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial.
Budde K, Prashar R, Haller H, Rial MC, Kamar N, Agarwal A, de Fijter JW, Rostaing L, Berger SP, Djamali A, Leca N, Allamassey L, Gao S, Polinsky M, Vincenti F. Budde K, et al. Among authors: kamar n. J Am Soc Nephrol. 2021 Dec 1;32(12):3252-3264. doi: 10.1681/ASN.2021050628. Epub 2021 Dec 1. J Am Soc Nephrol. 2021. PMID: 34706967 Free PMC article. Clinical Trial.
BACKGROUND: Calcineurin inhibitors (CNIs) are standard of care after kidney transplantation, but they are associated with nephrotoxicity and reduced long-term graft survival. Belatacept, a selective T cell costimulation blocker, is approved for the prophylaxis of kidney tr …
BACKGROUND: Calcineurin inhibitors (CNIs) are standard of care after kidney transplantation, but they are associated with nephrotoxicity and …
Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study.
Loupy A, Aubert O, Orandi BJ, Naesens M, Bouatou Y, Raynaud M, Divard G, Jackson AM, Viglietti D, Giral M, Kamar N, Thaunat O, Morelon E, Delahousse M, Kuypers D, Hertig A, Rondeau E, Bailly E, Eskandary F, Böhmig G, Gupta G, Glotz D, Legendre C, Montgomery RA, Stegall MD, Empana JP, Jouven X, Segev DL, Lefaucheur C. Loupy A, et al. Among authors: kamar n. BMJ. 2019 Sep 17;366:l4923. doi: 10.1136/bmj.l4923. BMJ. 2019. PMID: 31530561 Free PMC article. Clinical Trial.
OBJECTIVE: To develop and validate an integrative system to predict long term kidney allograft failure. DESIGN: International cohort study. ...Finally, the accuracy of the iBox risk score in predicting long term allograft loss was confirmed in the three randomised c …
OBJECTIVE: To develop and validate an integrative system to predict long term kidney allograft failure. DESIGN: International cohort …
An automated histological classification system for precision diagnostics of kidney allografts.
Yoo D, Goutaudier V, Divard G, Gueguen J, Astor BC, Aubert O, Raynaud M, Demir Z, Hogan J, Weng P, Smith J, Garro R, Warady BA, Zahr RS, Sablik M, Twombley K, Couzi L, Berney T, Boyer O, Duong-Van-Huyen JP, Giral M, Alsadi A, Gourraud PA, Morelon E, Le Quintrec M, Brouard S, Legendre C, Anglicheau D, Villard J, Zhong W, Kamar N, Bestard O, Djamali A, Budde K, Haas M, Lefaucheur C, Rabant M, Loupy A. Yoo D, et al. Among authors: kamar n. Nat Med. 2023 May;29(5):1211-1220. doi: 10.1038/s41591-023-02323-6. Epub 2023 May 4. Nat Med. 2023. PMID: 37142762
Finally, we found that reclassification of the initial diagnoses by the Banff Automation System was associated with an improved risk stratification of long-term allograft outcomes. This study demonstrates the potential of an automated histological classification to improve …
Finally, we found that reclassification of the initial diagnoses by the Banff Automation System was associated with an improved risk stratif …
Long-Term Kidney Transplant Outcomes: Role of Prolonged-Release Tacrolimus.
Banas B, Krämer BK, Krüger B, Kamar N, Undre N. Banas B, et al. Among authors: kamar n. Transplant Proc. 2020 Jan-Feb;52(1):102-110. doi: 10.1016/j.transproceed.2019.11.003. Epub 2019 Dec 31. Transplant Proc. 2020. PMID: 31901329 Free article. Review.
Tacrolimus has significantly improved outcomes for kidney transplant patients and remains the cornerstone of immunosuppressive therapy. While improvements in short-term outcomes in transplantation have been achieved in recent years, maintaining long-term graft survi …
Tacrolimus has significantly improved outcomes for kidney transplant patients and remains the cornerstone of immunosuppressive therapy. Whil …
Donor-specific antibodies and liver transplantation.
Del Bello A, Congy-Jolivet N, Danjoux M, Muscari F, Kamar N. Del Bello A, et al. Among authors: kamar n. Hum Immunol. 2016 Nov;77(11):1063-1070. doi: 10.1016/j.humimm.2016.02.006. Epub 2016 Feb 23. Hum Immunol. 2016. PMID: 26916836 Review.
Acute antibody-mediated rejection (AMR), plasma-cell hepatitis, biliary stricture, but also long-term complications, such as chronic rejection, liver ductopenia, and graft fibrosis, are now recognized to be associated with DSAs. ...
Acute antibody-mediated rejection (AMR), plasma-cell hepatitis, biliary stricture, but also long-term complications, such as chronic …
Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network.
Galmiche S, Thoreau B, Bretagne S, Alanio A, Paugam A, Letscher-Bru V, Cassaing S, Gangneux JP, Guegan H, Favennec L, Minoza A, Morio F, Bonhomme J, Desoubeaux G, Eloy O, Hasseine L, Sasso M, Millon L, Bellanger AP, Poirier P, Moniot M, Chouaki T, Huguenin A, Dalle F, Bouteille B, Nicolas M, Desbois-Nogard N, Bougnoux ME, Danion F, Poindron V, Néel A, Boukris-Sitbon K, Lanternier F, Terrier B; French Mycoses Study Group. Galmiche S, et al. RMD Open. 2023 Aug;9(3):e003281. doi: 10.1136/rmdopen-2023-003281. RMD Open. 2023. PMID: 37558492 Free PMC article.
OBJECTIVES: We aimed to describe patients with autoimmune diseases (AID) developing invasive fungal disease (IFD) and identify factors associated with short-term mortality. METHODS: We analysed cases of IFD associated with AID from the surveillance network of invasive fung …
OBJECTIVES: We aimed to describe patients with autoimmune diseases (AID) developing invasive fungal disease (IFD) and identify factors assoc …
Rationale for using belatacept in combination with sirolimus.
Wéclawiak H, Kamar N, Ould-Mohamed A, Cardeau-Desangles I, Rostaing L. Wéclawiak H, et al. Among authors: kamar n. Transplant Proc. 2010 Nov;42(9 Suppl):S29-31. doi: 10.1016/j.transproceed.2010.07.003. Transplant Proc. 2010. PMID: 21095447 Review.
Kidney transplantation can be used to replace failing native kidneys; however, it requires long-term immunosuppression, and immunological tolerance for this is not yet achievable. ...
Kidney transplantation can be used to replace failing native kidneys; however, it requires long-term immunosuppression, and immunolog …
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.
Neuberger JM, Bechstein WO, Kuypers DR, Burra P, Citterio F, De Geest S, Duvoux C, Jardine AG, Kamar N, Krämer BK, Metselaar HJ, Nevens F, Pirenne J, Rodríguez-Perálvarez ML, Samuel D, Schneeberger S, Serón D, Trunečka P, Tisone G, van Gelder T. Neuberger JM, et al. Among authors: kamar n. Transplantation. 2017 Apr;101(4S Suppl 2):S1-S56. doi: 10.1097/TP.0000000000001651. Transplantation. 2017. PMID: 28328734
Short-term patient and graft outcomes continue to improve after kidney and liver transplantation, with 1-year survival rates over 80%; however, improving longer-term outcomes remains a challenge. ...The clinical transplant community needs to identify and manage thos …
Short-term patient and graft outcomes continue to improve after kidney and liver transplantation, with 1-year survival rates over 80% …
Progression of histological lesions after ABO incompatible kidney transplantation.
Guy P, Delas A, Esposito L, Cointault O, Colombat M, Congy-Jolivet N, Raynaud M, Kamar N, Del Bello A. Guy P, et al. Among authors: kamar n. Front Immunol. 2022 Oct 6;13:969998. doi: 10.3389/fimmu.2022.969998. eCollection 2022. Front Immunol. 2022. PMID: 36275771 Free PMC article.
Recent large meta-analyses suggested a poorer long-term patients' and grafts' outcomes after ABO incompatible (ABOi) living-donor kidney transplantation (LDKT) compared to ABO compatible LDKT. ...The donor age was a predictive factor for the development of severe kidney al …
Recent large meta-analyses suggested a poorer long-term patients' and grafts' outcomes after ABO incompatible (ABOi) living-donor kid …
Autoimmune hepatitis recurrence after liver transplantation: "Les jeux sont faits".
Chouik Y, Corpechot C, Francoz C, De Martin E, Guillaud O, Abergel A, Altieri M, Barbier L, Besch C, Chazouillères O, Conti F, Dharancy S, Durand F, Duvoux C, Gugenheim J, Hardwigsen J, Hilleret MN, Houssel-Debry P, Kamar N, Minello A, Neau-Cransac M, Pageaux GP, Radenne S, Roux O, Saliba F, Samuel D, Vanlemmens C, Woehl-Jaegle ML, Leroy V, Duclos-Vallée JC, Dumortier J. Chouik Y, et al. Among authors: kamar n. Liver Transpl. 2024 Apr 1;30(4):395-411. doi: 10.1097/LVT.0000000000000278. Epub 2023 Oct 4. Liver Transpl. 2024. PMID: 37788303
Independent risk factors for these severe forms of rAIH were young age at LT, IgG levels >20.7 g/L, and LT in the context of (sub)fulminant hepatitis. Immunosuppression, especially long-term maintenance of corticosteroid therapy, was not significantly associated with rA …
Independent risk factors for these severe forms of rAIH were young age at LT, IgG levels >20.7 g/L, and LT in the context of (sub)fulmina …
82 results